“In producing any viral vector, the transfection reagent needs to guarantee both high titre and infectivity, as well as quality, to satisfy the needs of a particular disease indication,” says Deb.

Oxford, UK – 20 November 2024: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces it will host a free 60-minute webinar exploring how advanced robotics can be ...

In a groundbreaking leap for medical research, scientists have successfully cultivated miniature human brain models in the ...

This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

Local health and mosquito-control officials confirmed detection of the first imported case of Oropouche virus disease in the ...

Local health and mosquito-control officials have confirmed the Cayman Islands' first imported case of Oropouche virus disease ...

However, viruses can be reprogrammed to carry helpful genetic material. Axonis has modified a virus that is not harmful to ...